Immuron Ltd has released a press release.
Immuron achieves record monthly Travelan sales
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Immuron
- Immuron Receives TGA GMP Clearance
- Immuron enrols patients in Travelan clinical study
- Immuron FY23 Sales increase 136% on FY22 Sales
- Immuron Initiates Recruitment of Travelan Clinical Study
- FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic
Later from Immuron
- Immuron achieves record quarterly Travelan sales
- First Patients Enrolled in Campylobacter Clinical Study
- Immuron achieves record half yearly Travelan sales
- Immuron achieves record Travelan sales
- Travelan to progress to Phase 3 Clinical Trials in the US
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron